nach oben

European Archives of Psychiatry and Clinical Neuroscience

Erschienen in:

30.03.2017 | Original Paper

Effects of neonatal excitotoxic lesions in ventral thalamus on social interaction in the rat

verfasst von: Rainer Wolf, Henrik Dobrowolny, Sven Nullmeier, Bernhard Bogerts, Herbert Schwegler

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

The role of the thalamus in schizophrenia has increasingly been studied in recent years. Deficits in the ventral thalamus have been described in only few postmortem and neuroimaging studies. We utilised our previously introduced neurodevelopmental animal model, the neonatal excitotoxic lesion of the ventral thalamus of Sprague–Dawley rats (Wolf et al., Pharmacopsychiatry 43:99–109, 22). At postnatal day (PD7), male pubs received bilateral thalamic infusions with ibotenic acid (IBA) or artificial cerebrospinal fluid (control). In adulthood, social interaction of two animals not familiar to each other was studied by a computerised video tracking system. This study displays clear lesion effects on social interaction of adult male rats. The significant reduction of total contact time and the significant increase in distance between the animals in the IBA group compared to controls can be interpreted as social withdrawal modelling a negative symptom of schizophrenia. The significant increase of total distance travelled in the IBA group can be hypothesised as agitation modelling a positive symptom of schizophrenia. Using a triple concept of social interaction, the percentage of no social interaction (Non-SI%) was significantly larger, and inversely, the percentage of passive social interaction (SI-passive%) was significantly smaller in the IBA group when compared to controls. In conclusion, on the background of findings in schizophrenic patients, the effects of neonatal ventral thalamic IBA lesions in adult male rats support the hypothesis of face and construct validity as animal model of schizophrenia.

Kovelman JA, Scheibel AB (1984) A neurohistological correlate of schizophrenia. Biol Psychiatry 19:1601–1621PubMed

Jakob H, Beckmann H (1986) Prenatal developmental disturbances in the limbic allocortex in schizophrenics. J Neural Transm 65:303–326CrossRefPubMed

Bogerts B (1993) Recent advances in the neuropathology of schizophrenia. Schizophr Bull 19:431–445CrossRefPubMed

Lawrie SM, Abukmeil SS (1998) Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies. Br J Psychiatry 172:110–120CrossRefPubMed

Nelson MD, Saykin AJ, Flashman LA, Riordan HJ (1998) Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study. Arch Gen Psychiatry 55:433–440CrossRefPubMed

Wright IC, Rabe-Hesketh S, Woodruff PW, David AS, Murray RM, Bullmore ET (2000) Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry 157:16–25CrossRefPubMed

Weinberger DR (1987) Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44:660–669CrossRefPubMed

Bloom FE (1993) Advancing a neurodevelopmental origin for schizophrenia. Arch Gen Psychiatry 50:224–227CrossRefPubMed

Waddington JL (1993) Schizophrenia: developmental neuroscience and pathobiology. Lancet 341:531–536CrossRefPubMed

10.

Murray RM (1994) Neurodevelopmental schizophrenia: the rediscovery of dementia praecox. Br J Psychiatry Suppl 25:6–12

11.

Lipska BK, Jaskiw GE, Weinberger DR (1993) Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia. Neuropsychopharmacology 9:67–75CrossRefPubMed

12.

Fiore M, Talamini L, Angelucci F, Koch T, Aloe L, Korf J (1999) Prenatal methylazoxymethanol acetate alters behavior and brain NGF levels in young rats: a possible correlation with the development of schizophrenia-like deficits. Neuropharmacology 38:857–869CrossRefPubMed

13.

Schmadel S, Schwabe K, Koch M (2004) Effects of neonatal excitotoxic lesions of the entorhinal cortex on cognitive functions in the adult rat. Neuroscience 128:365–374CrossRefPubMed

14.

Sumiyoshi T, Tsunoda M, Uehara T, Tanaka K, Itoh H, Sumiyoshi C, Kurachi M (2004) Enhanced locomotor activity in rats with excitotoxic lesions of the entorhinal cortex, a neurodevelopmental animal model of schizophrenia: behavioral and in vivo microdialysis studies. Neurosci Lett 364:124–129CrossRefPubMed

15.

Harich S, Koch M, Schwabe K (2008) Effects of repeated dizocilpine treatment on adult rat behavior after neonatal lesions of the entorhinal cortex. Prog Neuropsychopharmacol Biol Psychiatry 32:816–827CrossRefPubMed

16.

Lipska BK, Al-Amin HA, Weinberger DR (1998) Excitotoxic lesions of the rat medial prefrontal cortex. Effects on abnormal behaviors associated with neonatal hippocampal damage. Neuropsychopharmacology 19:451–464CrossRefPubMed

17.

Schneider M, Koch M (2005) Deficient social and play behavior in juvenile and adult rats after neonatal cortical lesion: effects of chronic pubertal cannabinoid treatment. Neuropsychopharmacology 30:944–957CrossRefPubMed

18.

Daenen EW, Van Der Heyden JA, Kruse CG, Wolterink G, Van Ree JM (2001) Adaptation and habituation to an open field and responses to various stressful events in animals with neonatal lesions in the amygdala or ventral hippocampus. Brain Res 918:153–165CrossRefPubMed

19.

Bouwmeester H, Wolterink G, Van Ree JM (2002) Neonatal development of projections from the basolateral amygdala to prefrontal, striatal, and thalamic structures in the rat. J Comp Neurol 442:239–249CrossRefPubMed

20.

Daenen EW, Wolterink G, Van Der Heyden JA, Kruse CG, Van Ree JM (2003) Neonatal lesions in the amygdala or ventral hippocampus disrupt prepulse inhibition of the acoustic startle response; implications for an animal model of neurodevelopmental disorders like schizophrenia. Eur Neuropsychopharmacol 13:187–197CrossRefPubMed

21.

Lipska BK, Luu S, Halim ND, Weinberger DR (2003) Behavioral effects of neonatal and adult excitotoxic lesions of the mediodorsal thalamus in the adult rat. Behav Brain Res 141:105–111CrossRefPubMed

22.

Wolf R, Matzke K, Paelchen K, Dobrowolny H, Bogerts B, Schwegler H (2010) Reduction of prepulse inhibition (PPI) after neonatal excitotoxic lesion of the ventral thalamus in pubertal and adult rats. Pharmacopsychiatry 43:99–109CrossRefPubMed

23.

Lipska BK, Swerdlow NR, Geyer MA, Jaskiw GE, Braff DL, Weinberger DR (1995) Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology (Berl) 122:35–43CrossRef

24.

Sams-Dodd F, Lipska BK, Weinberger DR (1997) Neonatal lesions of the rat ventral hippocampus result in hyperlocomotion and deficits in social behaviour in adulthood. Psychopharmacology (Berl) 132:303–310CrossRef

25.

Jones EG (1997) Cortical development and thalamic pathology in schizophrenia. Schizophr Bull 23:483–501CrossRefPubMed

26.

Weinberger DR (1997) On localizing schizophrenic neuropathology. Schizophr Bull 23:537–540CrossRefPubMed

27.

Andreasen NC (1997) The role of the thalamus in schizophrenia. Can J Psychiatry 42:27–33CrossRefPubMed

28.

Heckers S (1997) Neuropathology of schizophrenia: cortex, thalamus, basal ganglia, and neurotransmitter-specific projection systems. Schizophr Bull 23:403–421CrossRefPubMed

29.

Byne W, Hazlett EA, Buchsbaum MS, Kemether E (2009) The thalamus and schizophrenia: current status of research. Acta Neuropathol 117:347–368CrossRefPubMed

30.

Cronenwett WJ, Csernansky J (2010) Thalamic pathology in schizophrenia. Curr Top Behav Neurosci 4:509–528CrossRefPubMed

31.

Konick LC, Friedman L (2001) Meta-analysis of thalamic size in schizophrenia. Biol Psychiatry 49:28–38CrossRefPubMed

32.

Clinton SM, Meador-Woodruff JH (2004) Thalamic dysfunction in schizophrenia: neurochemical, neuropathological, and in vivo imaging abnormalities. Schizophr Res 69:237–253CrossRefPubMed

33.

Sim K, Cullen T, Ongur D, Heckers S (2006) Testing models of thalamic dysfunction in schizophrenia using neuroimaging. J Neural Transm 113:907–928CrossRefPubMed

34.

Lisman J (2012) Excitation, inhibition, local oscillations, or large-scale loops: what causes the symptoms of schizophrenia? Curr Opin Neurobiol 22:537–544CrossRefPubMed

35.

Pakkenberg B (1990) Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Arch Gen Psychiatry 47:1023–1028CrossRefPubMed

36.

Danos P, Baumann B, Bernstein HG, Franz M, Stauch R, Northoff G, Krell D, Falkai P, Bogerts B (1998) Schizophrenia and anteroventral thalamic nucleus: selective decrease of parvalbumin-immunoreactive thalamocortical projection neurons. Psychiatry Res 82:1–10CrossRefPubMed

37.

Byne W, Buchsbaum MS, Mattiace LA, Hazlett EA, Kemether E, Elhakem SL, Purohit DP, Haroutunian V, Jones L (2002) Postmortem assessment of thalamic nuclear volumes in subjects with schizophrenia. Am J Psychiatry 159:59–65CrossRefPubMed

38.

Andreasen NC, Ehrhardt JC, Swayze VW, Alliger RJ, Yuh WT, Cohen G, Ziebell S (1990) Magnetic resonance imaging of the brain in schizophrenia. The pathophysiologic significance of structural abnormalities. Arch Gen Psychiatry 47:35–44CrossRefPubMed

39.

Buchsbaum MS, Someya T, Teng CY, Abel L, Chin S, Najafi A, Haier RJ, Wu J, Bunney WE Jr (1996) PET and MRI of the thalamus in never-medicated patients with schizophrenia. Am J Psychiatry 153:191–199CrossRefPubMed

40.

Brickman AM, Buchsbaum MS, Shihabuddin L, Byne W, Newmark RE, Brand J, Ahmed S, Mitelman SA, Hazlett EA (2004) Thalamus size and outcome in schizophrenia. Schizophr Res 71:473–484CrossRefPubMed

41.

Harms MP, Wang L, Mamah D, Barch DM, Thompson PA, Csernansky JG (2007) Thalamic shape abnormalities in individuals with schizophrenia and their nonpsychotic siblings. J Neurosci 27:13835–13842CrossRefPubMed

42.

Smith MJ, Wang L, Cronenwett W, Mamah D, Barch DM, Csernansky JG (2011) Thalamic morphology in schizophrenia and schizoaffective disorder. J Psychiatr Res 45:378–385CrossRefPubMed

43.

Crow TJ (1980) Molecular pathology of schizophrenia: more than one disease process? Br Med J 280:66–68CrossRefPubMedPubMedCentral

44.

Andreasen NC, Olsen S (1982) Negative v positive schizophrenia. Definition and validation. Arch Gen Psychiatry 39:789–794CrossRefPubMed

45.

File SE, Hyde JR (1978) Can social interaction be used to measure anxiety? Br J Pharmacol 62:19–24CrossRefPubMedPubMedCentral

46.

Meyerson BJ, Hoglund AU (1981) Exploratory and socio-sexual behaviour in the male laboratory rat: a methodological approach for the investigation of drug action. Acta Pharmacol Toxicol (Copenh) 48:168–180CrossRef

47.

Guy AP, Gardner CR (1985) Pharmacological characterisation of a modified social interaction model of anxiety in the rat. NeuropsychoBiology 13:194–200CrossRefPubMed

48.

Corbett R, Hartman H, Kerman LL, Woods AT, Strupczewski JT, Helsley GC, Conway PC, Dunn RW (1993) Effects of atypical antipsychotic agents on social behavior in rodents. Pharmacol Biochem Behav 45:9–17CrossRefPubMed

49.

File SE, Seth P (2003) A review of 25 years of the social interaction test. Eur J Pharmacol 463:35–53CrossRefPubMed

50.

Wolf, Dobrowolny, Bogerts (2002) Search for an animal model of schizophrenia: effects of neonatal temporolimbic lesions on social interaction in adult rats. Pharmacopsychiatry 35:11

51.

Wolf R, Dobrowolny H, Bogerts B (2004) Computergestützte Messung der sozialen Interaktion nach neonataler Ibotensäure-Läsion des temporolimbischen System der Ratte - ein Tiermodell der Schizophrenie? Nervenarzt 75(Suppl 2):S73

52.

Panther P, Nullmeier S, Dobrowolny H, Schwegler H, Wolf R (2012) CPB-K mice a mouse model of schizophrenia? Differences in dopaminergic, serotonergic and behavioral markers compared to BALB/cJ mice. Behav Brain Res 230:215–228CrossRefPubMed

53.

Zadeh LA (1965) Fuzzy sets. Inf Control 8:338–353CrossRef

54.

Klir GJ, Yuan B (1995) Fuzzy sets and fuzzy logic: theory and applications. Prentice Hall, New Jersey

55.

Pellegrino LJ, Pellegrino AS, Cushman AJ (1979) A stereotaxic atlas of the rat brain. Plenum, New York

56.

Ellenbroek BA, Cools AR (1990) Animal models with construct validity for schizophrenia. Behav Pharmacol 1:469–490CrossRefPubMed

57.

Lipska BK, Weinberger DR (1995) Genetic variation in vulnerability to the behavioral effects of neonatal hippocampal damage in rats. Proc Natl Acad Sci USA 92:8906–8910CrossRefPubMed

58.

Ouhaz Z, Ba-M’hamed S, Mitchell AS, Elidrissi A, Bennis M (2015) Behavioral and cognitive changes after early postnatal lesions of the rat mediodorsal thalamus. Behav Brain Res 292:219–232CrossRefPubMedPubMedCentral

59.

Geyer, Moghaddam B (2002) Animal models relevant to schizophrenia disorders. In: Davis KL, Charney DS, Coyle JT, Nemeroff C (eds) Neuropharmacology: the fifth generation of progress. Lippincott Williams and Wilkins, Philadelphia, pp 689–701

60.

Arguello PA, Gogos JA (2006) Modeling madness in mice: one piece at a time. Neuron 52:179–196CrossRefPubMed

61.

Adriano F, Spoletini I, Caltagirone C, Spalletta G (2010) Updated meta-analyses reveal thalamus volume reduction in patients with first episode and chronic schizophrenia. Schizophr Res 123:1–14CrossRefPubMed

62.

Meador-Woodruff JH, Clinton SM, Beneyto M, McCullumsmith RE (2003) Molecular abnormalities of the glutamate synapse in the thalamus in schizophrenia. Ann N Y Acad Sci 1003:75–93CrossRefPubMed

63.

Ferrarelli F, Tononi G (2011) The thalamic reticular nucleus and schizophrenia. Schizophr Bull 37:306–315CrossRefPubMed

64.

Oke AF, Adams RN (1987) Elevated thalamic dopamine: possible link to sensory dysfunctions in schizophrenia. Schizophr Bull 13:589–604CrossRefPubMed

65.

Oke AF, Putz C, Adams RN, Bird ED (1992) Neuroleptic treatment is an unlikely cause of elevated dopamine in thalamus of schizophrenic subjects. Psychiatry Res 45:203–208CrossRefPubMed

66.

Simon H, Le MM, Galey D, Cardo B (1976) Silver impregnation of dopaminergic systems after radiofrequency and 6-OHDA lesions of the rat ventral brain. Brain Res 115:215–231CrossRefPubMed

67.

Young KA, Randall PK, Wilcox RE (1995) Startle and sensorimotor correlates of ventral thalamic dopamine and GABA in rodents. Neuroreport 6:2495–2499CrossRefPubMed

68.

Simpson EH, Winiger V, Biezonski DK, Haq I, Kandel ER, Kellendonk C (2014) Selective overexpression of dopamine D3 receptors in the striatum disrupts motivation but not cognition. Biol Psychiatry 76:823–831CrossRefPubMed

69.

Clinton SM, Haroutunian V, Davis KL, Meador-Woodruff JH (2003) Altered transcript expression of NMDA receptor-associated postsynaptic proteins in the thalamus of subjects with schizophrenia. Am J Psychiatry 160:1100–1109CrossRefPubMed

70.

Clinton SM, Haroutunian V, Meador-Woodruff JH (2006) Up-regulation of NMDA receptor subunit and post-synaptic density protein expression in the thalamus of elderly patients with schizophrenia. J Neurochem 98:1114–1125CrossRefPubMed

71.

Wiedholz LM, Owens WA, Horton RE, Feyder M, Karlsson R-M, Hefner K, Sprengel R, Celikel T, Daws LC, Holmes A (2014) Mice lacking the AMPA GluR1 receptor exhibit striatal hyperdopaminergia and ‘schizophrenia-related’ behaviors. Mol Psychiatry 13:631–640CrossRef

72.

Inta D, Miriam A, Vogt MA, Elkin H, Weber T, Juan M, Lima-Ojeda JM, Schneider M, Luoni A, Riva MA, Gertz K, Hellmann-Regen J, Kronenberg G, Meyer-Lindenberg A, Sprengel R, Gass P (2014) Phenotype of mice with inducible ablation of GluA1 AMPA receptors during late adolescence: relevance for mental disorders. Hippocampus 24:424–435CrossRefPubMed

73.

Wolf R, Dobrowolny H, Matzke K, Paelchen K, Bogerts B, Schwegler H (2006) Prepulse inhibition is different in two inbred mouse strains (CPB-K and BALB/cJ) with different hippocampal NMDA receptor densities. Behav Brain Res 166:78–84CrossRefPubMed

74.

DiChiara G, Morelli M, Porceddu ML, Gessa GL (1979) Role of thalamic gamma-aminobutyrate in motor functions: catalepsy and ipsiversive turning after intrathalamic muscimol. Neuroscience 4:1453–1465CrossRef

75.

Carlsson A, Lindqvist M (1963) Effect of chlorpromazine or haloperidol on formation of 3methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol (Copenh) 20:140–144CrossRef

76.

van Rossum JM (1966) The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs. Arch Int Pharmacodyn Ther 160:492–494PubMed

77.

Olney JW, Farber NB (1995) Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52:998–1007CrossRefPubMed

78.

Olney JW, Newcomer JW, Farber NB (1999) NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res 33:523–533CrossRefPubMed

79.

Tamminga C (1999) Glutamatergic aspects of schizophrenia. Br J Psychiatry Suppl 37:12–15

80.

Carlsson A, Waters N, Carlsson ML (2000) Network interactions in schizophrenia—therapeutic implications. Brain Res Rev 31:342–349CrossRefPubMed

81.

Benes FM (2000) Emerging principles of altered neural circuitry in schizophrenia. Brain Res Rev 31:251–269CrossRefPubMed

82.

Lewis DA (2000) GABAergic local circuit neurons and prefrontal cortical dysfunction inschizophrenia. Brain Res Rev 31:270–276CrossRefPubMed

83.

Sharp FR, Tomitaka M, Bernaudin M, Tomitaka S (2001) Psychosis: pathological activation of limbic thalamocortical circuits by psychomimetics and schizophrenia? Trends Neurosci 24:330–334CrossRefPubMed

Titel: Effects of neonatal excitotoxic lesions in ventral thalamus on social interaction in the rat
verfasst von: Rainer Wolf
Henrik Dobrowolny
Sven Nullmeier
Bernhard Bogerts
Herbert Schwegler
Publikationsdatum: 30.03.2017
Verlag: Springer Berlin Heidelberg
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 5/2018
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI: https://doi.org/10.1007/s00406-017-0781-2

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2018

Planning functioning and impulsiveness in obsessive–compulsive disorder

Plasma levels of soluble amyloid precursor protein β in symptomatic Alzheimer’s disease

No difference in the prevalence of Alzheimer-type neurodegenerative changes in the brains of suicides when compared with controls: an explorative neuropathologic study

Articulation and testing of a personality-centred model of psychopathology: evidence from a longitudinal community study over 30 years